These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24401940)

  • 1. Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
    Kam-Hansen S; Jakubowski M; Kelley JM; Kirsch I; Hoaglin DC; Kaptchuk TJ; Burstein R
    Sci Transl Med; 2014 Jan; 6(218):218ra5. PubMed ID: 24401940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2004; 44(7):669-73. PubMed ID: 15209688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rizatriptan for acute migraine.
    Oldman AD; Smith LA; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003221. PubMed ID: 11687054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
    Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G
    Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Mateos V; Roig C; López Rodríguez I; López-Gil A
    Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
    Misra UK; Kalita J; Yadav RK
    J Headache Pain; 2007 Jun; 8(3):175-9. PubMed ID: 17563841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
    Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
    Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
    Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
    Cutler NR; Jhee SS; Majumdar AK; McLaughlin D; Brucker MJ; Carides AD; Kramer MS; Matzura-Wolfe D; Reines SA; Goldberg MR
    Headache; 1999 Apr; 39(4):264-9. PubMed ID: 15613223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rizatriptan in the treatment of menstrual migraine.
    Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR
    Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.